Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis

Background Iron metabolism plays a significant role in the development of metabolic disorders in women with polycystic ovary syndrome (PCOS). Despite the importance of hepcidin, a key iron regulator, current research on serum hepcidin levels in PCOS patients shows conflicting results.Methods PubMed,...

Full description

Saved in:
Bibliographic Details
Main Authors: Jieou Nong, Hua Li, Yunfei Yang, Qiujie Lu, Yifan Sun, Qi Yin, Hongying He
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Gynecological Endocrinology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/09513590.2024.2375568
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850104244946862080
author Jieou Nong
Hua Li
Yunfei Yang
Qiujie Lu
Yifan Sun
Qi Yin
Hongying He
author_facet Jieou Nong
Hua Li
Yunfei Yang
Qiujie Lu
Yifan Sun
Qi Yin
Hongying He
author_sort Jieou Nong
collection DOAJ
description Background Iron metabolism plays a significant role in the development of metabolic disorders in women with polycystic ovary syndrome (PCOS). Despite the importance of hepcidin, a key iron regulator, current research on serum hepcidin levels in PCOS patients shows conflicting results.Methods PubMed, Embase, Web of Science, Cochrane Library and the China National Knowledge Infrastructure (CNKI) database were systematically searched from their inception to 9 September 2023. The search aimed to identify studies in English and Chinese that examined hepcidin levels in women with PCOS compared to healthy control subjects. Standardized mean differences (SMDs) with corresponding 95% confidence intervals (95% CIs) were calculated to evaluate the difference in serum hepcidin levels between women with and without PCOS.Results The meta-analysis included a total of 10 eligible studies, which encompassed 499 PCOS patients and 391 control subjects. The pooled analysis revealed a significant reduction in serum hepcidin levels among the PCOS patients compared to the healthy controls (SMD = −3.49, 95% CI: −4.68 to −2.30, p < .05). There was no statistically significant difference in serum hepcidin levels between PCOS patients with a body mass index (BMI) < 25 and those with a BMI ≥ 25 (p > .05).Conclusion The serum hepcidin levels of women with PCOS were significantly lower than those of healthy controls, which suggests that serum hepcidin could be a potential biomarker for PCOS.
format Article
id doaj-art-b87fa919b64744a4a3b89ed46b9938cd
institution DOAJ
issn 0951-3590
1473-0766
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Gynecological Endocrinology
spelling doaj-art-b87fa919b64744a4a3b89ed46b9938cd2025-08-20T02:39:22ZengTaylor & Francis GroupGynecological Endocrinology0951-35901473-07662024-12-0140110.1080/09513590.2024.2375568Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysisJieou Nong0Hua Li1Yunfei Yang2Qiujie Lu3Yifan Sun4Qi Yin5Hongying He6Department of Clinical Laboratory, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, ChinaDepartment of Clinical Laboratory, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, ChinaDepartment of Clinical Laboratory, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, ChinaDepartment of Clinical Laboratory, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, ChinaDepartment of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People’s Hospital, Guigang, Guangxi, ChinaDepartment of Clinical Laboratory, Liuzhou Municipal Liutie Central Hospital, Liuzhou, ChinaDepartment of Gynecology, Liuzhou Municipal Liutie Central Hospital, Liuzhou, ChinaBackground Iron metabolism plays a significant role in the development of metabolic disorders in women with polycystic ovary syndrome (PCOS). Despite the importance of hepcidin, a key iron regulator, current research on serum hepcidin levels in PCOS patients shows conflicting results.Methods PubMed, Embase, Web of Science, Cochrane Library and the China National Knowledge Infrastructure (CNKI) database were systematically searched from their inception to 9 September 2023. The search aimed to identify studies in English and Chinese that examined hepcidin levels in women with PCOS compared to healthy control subjects. Standardized mean differences (SMDs) with corresponding 95% confidence intervals (95% CIs) were calculated to evaluate the difference in serum hepcidin levels between women with and without PCOS.Results The meta-analysis included a total of 10 eligible studies, which encompassed 499 PCOS patients and 391 control subjects. The pooled analysis revealed a significant reduction in serum hepcidin levels among the PCOS patients compared to the healthy controls (SMD = −3.49, 95% CI: −4.68 to −2.30, p < .05). There was no statistically significant difference in serum hepcidin levels between PCOS patients with a body mass index (BMI) < 25 and those with a BMI ≥ 25 (p > .05).Conclusion The serum hepcidin levels of women with PCOS were significantly lower than those of healthy controls, which suggests that serum hepcidin could be a potential biomarker for PCOS.https://www.tandfonline.com/doi/10.1080/09513590.2024.2375568Polycystic ovary syndromehepcidiniron metabolismmeta-analysis
spellingShingle Jieou Nong
Hua Li
Yunfei Yang
Qiujie Lu
Yifan Sun
Qi Yin
Hongying He
Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis
Gynecological Endocrinology
Polycystic ovary syndrome
hepcidin
iron metabolism
meta-analysis
title Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis
title_full Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis
title_fullStr Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis
title_full_unstemmed Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis
title_short Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis
title_sort low serum hepcidin levels in women with polycystic ovary syndrome evidence from meta analysis
topic Polycystic ovary syndrome
hepcidin
iron metabolism
meta-analysis
url https://www.tandfonline.com/doi/10.1080/09513590.2024.2375568
work_keys_str_mv AT jieounong lowserumhepcidinlevelsinwomenwithpolycysticovarysyndromeevidencefrommetaanalysis
AT huali lowserumhepcidinlevelsinwomenwithpolycysticovarysyndromeevidencefrommetaanalysis
AT yunfeiyang lowserumhepcidinlevelsinwomenwithpolycysticovarysyndromeevidencefrommetaanalysis
AT qiujielu lowserumhepcidinlevelsinwomenwithpolycysticovarysyndromeevidencefrommetaanalysis
AT yifansun lowserumhepcidinlevelsinwomenwithpolycysticovarysyndromeevidencefrommetaanalysis
AT qiyin lowserumhepcidinlevelsinwomenwithpolycysticovarysyndromeevidencefrommetaanalysis
AT hongyinghe lowserumhepcidinlevelsinwomenwithpolycysticovarysyndromeevidencefrommetaanalysis